Table of Contents
PharmSights
| Abuse Potential of Soma®: the GABAA Receptor as a Target |
Abstract PDF |
| Lorie A. Gonzalez, Michael B. Gatch, Michael J. Forster, Glenn H. Dillon |
180-186 |
| Voglibose, an Alpha-glucosidase Inhibitor, to Increase Active Glucagon-like Peptide-1 Levels |
Abstract PDF |
| Yusuke Moritoh, Koji Takeuchi, Masatoshi Hazama |
188-192 |
| Targeting Chronic Pain with Epigenetic Drugs: Focus on mGlu2 Receptors |
Abstract PDF |
| Santina Chiechio, Magda Zammataro, Robert W. Gereau IV, Agata Copani, Ferdinando Nicoletti |
194-199 |
Research Articles
| Human Prostate Cancer Cells Secrete Neuro-Protective Factors in Response to Cryotherapy |
Abstract PDF |
| Seema Gupta, Mini Varghese, Mohammed M. Shareef, Mansoor M. Ahmed |
200-206 |
| Enhancement of Gamma Radiation-induced Cytotoxicity of Breast Cancer Cells by Curcumin |
Abstract PDF |
| Swati Girdhani, Mansoor M. Ahmed, Kaushala P. Mishra |
208-217 |
Reviews
| Seleno-L-Methionine Modulation of Nucleotide Excision DNA Repair Relevant to Cancer Prevention and Chemotherapy |
Abstract PDF |
| Martin L. Smith, M.A. Suresh Kumar |
218-221 |
| Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy |
Abstract PDF |
| Jaclyn L. Kovach, Stephen G. Schwartz |
222-227 |
Corrigenda
| Corrigendum to: Differentiation of cochlear neural progenitors with SV40 in vitro. Mol Cell Pharmacol 2009;1:11-22 |
PDF |
| Jizhen Lin |
228 |
FDA Corner
| FDA Approves New Drug to Treat Psoriasis |
Abstract PDF |
| |
230 |
| FDA Approves First Drug for Treatment of Peripheral T-cell Lymphoma |
Abstract PDF |
| |
230-231 |
| FDA Approves Vaccines for 2009 H1N1 Influenza Virus |
Abstract PDF |
| |
231 |
| FDA Approves New Cholesterol-Lowering Drug |
Abstract PDF |
| |
232 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
